本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

37.37
+0.37001.00%
盘后37.370.00000.00%18:58 EDT
成交量:84.25万
成交额:3,147.35万
市值:41.33亿
市盈率:-15.07
高:37.84
开:37.20
低:37.10
收:37.00
数据加载中...
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report